Futibatinib is approved for adults with previously treated, unresectable, locally advanced, or metastatic intrahepatic #cholangiocarcinoma harboring FGFR2 gene fusions. It received FDA approval through the accelerated approval pathway. ow.ly/8Js850OVOxA
Can everyone please share this as much as possible to get Gene Simmons or KISS Paul Stanley to see this! #kissarmy #godgaverockandrolltoyou
#cholangiocarcinoma
Arndt Vogel concludes the #EASLCongress PG course with discussion about cholangiocarcinoma. Increasing treatment options. Molecular testing recommended for treatment selection #LiverTwitter EASL Education
FGFR Inhibition in Cholangiocarcinoma: What Are the Options? #PeerVoice #meded #oncology #cholangiocarcinoma #FGFR
peervoice.com/RTV?PromoCode=…
#thinktank on systemic treatment pf #HCC and #cholangiocarcinoma has started Angela Lamarca showed data on combination of systemic tx with lororegional txs. #EASLCongress
Novel Approaches for Targeting #FGFR Alterations in #CCA #cholangiocarcinoma Angela Lamarca Arndt Vogel Humanitas University Humanitas Milano ILCA AMMF ENS-CCA Cholangiocarcinoma Foundation EURO-CHOLANGIO-NET Global Cholangiocarcinoma Alliance
The genomic profiles of patients with #Cholangiocarcinoma , who are 45 years of age and younger, are different than that of patients older than 45 years of age, found a new study published in the journal Cancer Biology and Therapy.
➡️ Read more: fal.cn/3zm2N
Sebden sponsored and would like to congratulate Scott Oddy and his team for successfully completing the National Three Peaks Challenge (Ben Nevis/Scafell Pike/Snowden).
The team did a brilliant job and raised £1669 for AMMF, the UK’s only cholangiocarcinoma charity.
#SebdenSteel
🔎Looking for a lab hosting your MarieSkłodowskaCurie fellowship?🧑🔬
👉Don't miss our new program 'COST for MSCA'!
✅Platform of available hosting mentors/labs in our network 🥼
✅Training for developing a successful application 📝
🗓️ 1st webinar: 26 June
🌐Info: bit.ly/CholangioMSCA
Super proud of Sara Teles presenting her work on #cholangiocarcinoma ! EASLnews thank you for supporting young talent with amazing bursaries! Cancer Research UK in Scotland MRC_HGU
Jesus Bañales now discussing cholangiocarcinoma in patients with NAFLD. NAFLD increases risk of CCa by 3 fold (NASH, not simple steatosis). #LiverTwitter #EASLCongress EASL Education Global Cholangiocarcinoma Alliance Cholangiocarcinoma Foundation
🔥Options & Opportunities in #Cholangiocarcinoma : Novel Approaches for Targeting FGFR Alterations
🧐What Are the Options? Interested?
👉PeerVoice activity by Angela Lamarca Lorenza Rimassa & Arndt Vogel
👇 ime2.peervoice.com/505204742/5052…
ESMO - Eur. Oncology OncoAlert @Easledu Milca Malary Cholangiocarcinoma Foundation…
One year ago today my father passed away from #Cholangiocarcinoma or #bileductcancer ...precursor for that was #hepatitisb infection which usually causes this very rare and very aggressive cancer that spreads very fast. Average age for this condition is 70, my dad was 64.